Search and analyze individual stocks with comprehensive metrics
Ambalal Sarabhai Enterprises Ltd
Fundamental Score
Ambalal Sarabhai Enterprises Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of AMBALALSA across key market metrics for learning purposes.
Positive Indicators
2 factors identified
Attractive Valuation (P/E: 13.99 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
9 factors identified
Below-Average Return on Equity (6.25%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (9.12%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Profit Decline Concern (-121.37%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.
Weak Earnings Growth (-8.94% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation. Consider growth catalysts and competitive positioning.
Stagnant Profit Growth (-8.94% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity. Assess transformation initiatives.
Negative Free Cash Flow (₹-5.46 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
Limited Institutional Interest (FII+DII: 0.34%)
Observation: Low institutional participation may affect liquidity and visibility.
Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Loading Peer Comparison
Finding companies in the Pharmaceuticals sector...
Financial Statements
Comprehensive financial data for Ambalal Sarabhai Enterprises Ltd
About AMBALALSA
Business Overview
Ambalal Sarabhai Enterprises Limited, together with its subsidiaries, manufactures, markets, and supplies pharmaceutical products in India and internationally. The company offers products for oncology, infertility, and uro-gynaec areas; generic and veterinary products; antifungal active ingredient products; vitamin C coated products; and analytical, test, and measuring instruments, as well as supplies finished dosage forms and active pharmaceutical ingredients. It also provides broadcast and professional video/audio, and electronic products. Ambalal Sarabhai Enterprises Limited was incorporated in 1977 and is based in Ahmedabad, India.
Company Details
Key Leadership
AMBALALSA Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Ambalal Sarabhai Enterprises Ltd (AMBALALSA)?
As of 19 Jan 2026, 10:13 am IST, Ambalal Sarabhai Enterprises Ltd (AMBALALSA) is currently trading at ₹26.30. The stock has a market capitalization of ₹218.56 (Cr).
Is AMBALALSA share price Overvalued or Undervalued?
AMBALALSA is currently trading at a P/E ratio of 13.99x, compared to the industry average of 31.77x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.
What factors affect the Ambalal Sarabhai Enterprises Ltd share price?
Key factors influencing AMBALALSA's price include its quarterly earnings growth (Sales Growth: -0.56%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Ambalal Sarabhai Enterprises Ltd a good stock for long-term investment?
Ambalal Sarabhai Enterprises Ltd shows a 5-year Profit Growth of -8.94% and an ROE of 6.25%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.32 before investing.
How does Ambalal Sarabhai Enterprises Ltd compare with its industry peers?
Ambalal Sarabhai Enterprises Ltd competes with major peers in the Pharmaceuticals. Investors should compare AMBALALSA's P/E of 13.99x and ROE of 6.25% against the industry averages to determine its competitive standing.
What is the P/E ratio of AMBALALSA and what does it mean?
AMBALALSA has a P/E ratio of 13.99x compared to the industry average of 31.77x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹14 for every ₹1 of annual earnings.
How is AMBALALSA performing according to Bull Run's analysis?
AMBALALSA has a Bull Run fundamental score of 17.2/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does AMBALALSA belong to?
AMBALALSA operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Ambalal Sarabhai Enterprises Ltd.
What is Return on Equity (ROE) and why is it important for AMBALALSA?
AMBALALSA has an ROE of 6.25%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Ambalal Sarabhai Enterprises Ltd generates profits from shareholders' equity.
How is AMBALALSA's debt-to-equity ratio and what does it indicate?
AMBALALSA has a debt-to-equity ratio of 0.32, which indicates moderate leverage that should be monitored. A ratio below 1.0 generally indicates conservative financing.
What is AMBALALSA's dividend yield and is it a good dividend stock?
AMBALALSA offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has AMBALALSA grown over the past 5 years?
AMBALALSA has achieved 5-year growth rates of: Sales Growth 8.08%, Profit Growth -8.94%, and EPS Growth -8.94%.
What is the promoter holding in AMBALALSA and why does it matter?
Promoters hold 31.35% of AMBALALSA shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is AMBALALSA's market capitalization category?
AMBALALSA has a market capitalization of ₹219 crores, placing it in the Small-cap category.
How volatile is AMBALALSA stock?
AMBALALSA has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for AMBALALSA?
AMBALALSA has a 52-week high of ₹N/A and low of ₹N/A.
What is AMBALALSA's operating profit margin trend?
AMBALALSA has a 5-year average Operating Profit Margin (OPM) of 5.24%, indicating the company's operational efficiency.
How is AMBALALSA's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of -0.56% and YoY Profit Growth of -121.37%.
What is the institutional holding pattern in AMBALALSA?
AMBALALSA has FII holding of 0.34% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.